| 1 |
2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7382).
|
| 3 |
Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
|
| 4 |
ClinicalTrials.gov (NCT04071262) A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
|
| 5 |
ClinicalTrials.gov (NCT02117648) A Study of LY2835219 in Participants With Cancer
|
| 6 |
ClinicalTrials.gov (NCT02057133) A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
|
| 7 |
ClinicalTrials.gov (NCT01394016) A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
|
| 8 |
ClinicalTrials.gov (NCT02079636) A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
|
| 9 |
ClinicalTrials.gov (NCT05789771) Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.
|
| 10 |
ClinicalTrials.gov (NCT04238819) A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
|
| 11 |
ClinicalTrials.gov (NCT04316169) Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
|
| 12 |
ClinicalTrials.gov (NCT03905889) A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
|
| 13 |
ClinicalTrials.gov (NCT02784795) A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.
|
| 14 |
ClinicalTrials.gov (NCT05095207) Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
|
| 15 |
ClinicalTrials.gov (NCT04481113) Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
|
| 16 |
ClinicalTrials.gov (NCT04633239) Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
|
| 17 |
ClinicalTrials.gov (NCT05563220) Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
|
| 18 |
ClinicalTrials.gov (NCT05386108) Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer
|
| 19 |
ClinicalTrials.gov (NCT04791384) Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
|
| 20 |
ClinicalTrials.gov (NCT05714072) A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
|
| 21 |
ClinicalTrials.gov (NCT05501704) ETHAN - ET for Male BC
|
| 22 |
ClinicalTrials.gov (NCT04256941) Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
|
| 23 |
ClinicalTrials.gov (NCT05524584) Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
|
| 24 |
ClinicalTrials.gov (NCT04603183) ABemaciclib, ET paclItaxel in aGgressive HR+/HER2- MBC trIaL
|
| 25 |
ClinicalTrials.gov (NCT02441946) A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
|
| 26 |
ClinicalTrials.gov (NCT04469764) Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
|
| 27 |
ClinicalTrials.gov (NCT04293393) Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
|
| 28 |
ClinicalTrials.gov (NCT03675893) Abemaciclib + Letrozole +/- Metformin in Recurrent or Persistent Endometrial Cancer
|
| 29 |
ClinicalTrials.gov (NCT05999994) A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
|
| 30 |
ClinicalTrials.gov (NCT05440786) CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
|
| 31 |
ClinicalTrials.gov (NCT04523857) ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
|
| 32 |
ClinicalTrials.gov (NCT04545710) Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
|
| 33 |
ClinicalTrials.gov (NCT02763566) A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
|
| 34 |
ClinicalTrials.gov (NCT02246621) A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
|
|
|
|
|
|
|
